Market Overview
The global surgical planning software market was valued at $102.1 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030. Surgical Planning software helps surgeons decide on the best approach by generating digital data that surgeons can evaluate quickly before surgery. Technological advancement in surgical planning software, increasing incidence of orthopaedic surgery, and growing adult population worldwide are some of the major factors contributing to the growth of the market.
The digital surgical technologies market is currently witnessing major changes in the business environment. Investments in health promotion are increasing, and there is growing evidence of effective and efficient
Market Growth and Trends
The global surgical planning software market size is expected to reach $167.9 million by 2030. The market is predicted to grow from 2023 to 2030 with a CAGR of 6.5%. Technological development Urine in healthcare has increased the urgent need for healthcare, medical care, and the elderly as a major workforce worldwide.
Planning and visualizing the surgery is an important part of patient care, including the patient’s unique anatomy, procedures, and desired outcomes. The steps before entering the operating room can affect the duration of the surgery, the expected outcome, reduction of complications and ultimately patient satisfaction. In addition, the surgical plan facilitates the evaluation of physical therapy and accelerates the interpretation of the disease.
Large companies in the market seek to improve their products by developing their products, entering into large partnerships, and reviewing government permits and standards in order to develop their customers and have a larger business. For example, in February 2022, 3D Systems announced an agreement to acquire kumovis, a medical solutions specialist based in Munich, Germany.
In the near future, technology assistance allow 3D systems to add extrusion equipment to its broad medical portfolio, allowing the company to expand its business in medical, medical and applied products.
Market Challenges
Regulatory changes will increase the costs associated with developing new products and serving patients. These changes relate to changes in consumer protection and device approval processes, such as the European Union’s General Data Protection Regulation (GDPR). The U.S. Food and Drug Administration (FDA) needs more clinical data to support the safety and effectiveness of uptime-enhancing medical devices, such as endoscopic devices. Standard 510(k) approvals were first introduced a few years ago. 55% Loss of revenue, perhaps due to delayed exports, and additional costs due to tight agreement make it difficult to invest in related new products for the development of medical devices and products.
COVID-19 Analysis
The COVID-19 pandemic has disrupted daily healthcare, resulting in fewer hospitalizations, rescheduling of surgical services, and delays in cancer screening. The first wave of the COVID-19 pandemic has had a huge impact on global health.
Reductions in hospitals and theatres led to significant disruptions in intensive care and partial treatments. According to the Annals of Surgery article, the pandemic has disrupted surgical services, with nearly 28 million surgeries cancelled and tests removed worldwide during the first wave of COVID-19. And is affected.
Market Size and Segmentation
- Deployment
- On-premise
- Cloud-based
The cloud-based software segment will have the largest revenue share at 64.6% in 2022 and is expected to continue to dominate with the fastest growth rate of 6.7% during the specific period. The cloud-based software includes great features like development tools, demand cycles, and access to a wide variety of resources, including application storage. Cloud apps can run fully or partially offline, which is useful for platforms with slow internet connections.
- Application
- Dental and Orthodontics
- Orthopaedic Surgery
- Neurosurgery
- Others
The orthopaedic surgery market segment represents the largest revenue growth of 41.5% through 2022. Preoperative planning is one of the most important steps in surgery. Preoperative planning for elective treatments such as total transplant can reduce operative time and patient length of stay (LOS). Recent advances in technology are helping plastic surgeons plan their surgeries more accurately and improve their performance.
Additionally, surgeons can use orthopaedic design software to determine the size and position of the orthopaedic implant to ensure it fits the patient’s anatomy.
- End-use
- Specialty Clinics
- Hospitals
Hospital segment, offered by the Centres for Disease Control and Prevention (CDC), holds the majority of the market at approximately 54% through 2022 and is expected to grow at the fastest growth rate of 6.8% during the look-up duration. Effective healthcare planning can help hospitals and clinics increase efficiency, improve patient communication, and provide consistent and transparent care to patients.
In advanced surgery, it is more common to use an approach that includes the characteristics of the patient. The cutting and pre-operative planning method allows for the optimization of the process, which is rare for the patient.
- Regional
- North America
- Canada
- U.S.
- Europe
- Russia
- U.K.
- Spain
- Germany
- Italy
- France
- Asia Pacific
- Singapore
- Japan
- South Korea
- China
- Australia
- India
- Latin America
- Argentina
- Brazil
- Colombia
- Mexico
- Middle East and Africa
- Israel
- South Africa
- UAE
- Saudi Arabia
North America will dominate the market with a revenue of 42.3% by 2022 due to the rapid development of technology in the medical and healthcare sectors in the region. The allocation of funds for medical R&D has had a significant impact on the growth of the North American surgical planning software market over the past few years. The market is expected to increase as there are many healthcare initiatives undertaken by various institutions and organizations. Financial data for most health plans in the United States.
Competitive Analysis
The global digital surgery market consists of many large and small companies and suppliers. Now with the increasing use of artificial intelligence in healthcare, there are many opportunities for companies in the industry to expand their products and hold on to the market.
In the last few years, the technology sector has seen approximately 47 partnerships, collaborations and expansions, 43 new products, 15 management and approvals, 33 financial operations, 13 mergers and acquisitions. 11 buying and selling.
Most companies in the industry collaborate not only with other companies, but also with hospitals, medical schools, medical centres and surgeons.
The study accurately and reliably estimates the market share of key segments of the virtual surgery planning market. Investors can use this research to make business investments in the significant growth of the virtual job market.
Key Competitors
- Stryker
- Renishaw Plc.
- Zimmer Biomet.
- General Electric Company
- Medtronic
- CANON MEDICAL SYSTEMS USA, INC.
- Materialise
- DePuy Synthes (Johnson & Johnson Medical Devices Companies)
- Brainlab AG
- mediCAD Hectec GmbH
- 3D Systems Inc.